Published 27 May 2009, doi:10.1136/bmj.b2098
Cite this as: BMJ 2009;338:b2098

Letters

Larval therapy for leg ulcers

Study authors respond to points in editorial

The first 150 words of the full text of this article appear below.

In the editorial accompanying our three papers on leg ulcers, Grey and colleagues make several points that deserve reply.1 2 3 4

They do not like our selection of time to healing as the primary outcome in the larval therapy study, but debridement is practised precisely because it is thought to aid healing. They claim that debridement "is more valuable to clinicians," but is it more valuable to patients if it is not associated with quicker healing? We are baffled by their declaration that "it may be unrealistic to use complete healing as the primary outcome measure in wound healing studies, and time to healing may be an equally valid outcome measure" because time to healing was our primary end point, and, anyway, both complete healing and time to healing rely on the occurrence of healing.

We used extremely broad inclusion criteria for the larval therapy trial. The main reason for exclusion was . . . [Full text of this article]

Nicky Cullum, deputy head of department (research)1, Martin Bland, professor of health statistics1, Jo Dumville, research fellow1, Cynthia Iglesias, senior research fellow1, Susan O’Meara, research fellow1, Marta Soares, research fellow1, David Torgerson, professor, director York trials unit1, Andrea Nelson, reader in wound healing and director of research2, Gill Worthy, trial statistician2

1 Department of Health Sciences, University of York, York YO10 5DD, 2 School of Healthcare, University of Leeds

nac2@york.ac.uk


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Four layer bandage compared with short stretch bandage for venous leg ulcers: systematic review and meta-analysis of randomised controlled trials with data from individual patients
Susan O’Meara, Jayne Tierney, Nicky Cullum, J Martin Bland, Peter J Franks, Trevor Mole, and Mark Scriven
BMJ 2009 338: b1344. [Abstract] [Full Text] [PDF]

How to measure success in treating chronic leg ulcers
Joseph E Grey, David Leaper, and Keith Harding
BMJ 2009 338: b1434. [Extract] [Full Text]

Larval therapy for leg ulcers (VenUS II): randomised controlled trial
Jo C Dumville, Gill Worthy, J Martin Bland, Nicky Cullum, Christopher Dowson, Cynthia Iglesias, Joanne L Mitchell, E Andrea Nelson, Marta O Soares, David J Torgerson on behalf of the VenUS II team
BMJ 2009 338: b773. [Abstract] [Full Text] [PDF]

Cost effectiveness analysis of larval therapy for leg ulcers
Marta O Soares, Cynthia P Iglesias, J Martin Bland, Nicky Cullum, Jo C Dumville, E Andrea Nelson, David J Torgerson, Gill Worthy on behalf of the VenUS II team
BMJ 2009 338: b825. [Abstract] [Full Text] [PDF]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ